Continuous TQL Block for Elective Cesarean Section
Ultrasound-guided Transmuscular Quadratus Lumborum Catheters for Elective Caesarean Section. A Double Blind, Randomise, Placebo Controlled Trial.
1 other identifier
interventional
32
1 country
1
Brief Summary
The aim of this study is to investigate whether it is possible to prolong time to first opioid with the TQL block by inserting catheters bilaterally, providing continuous analgesia, in patients undergoing elective CS. Our hypothesis is that it will be possible to significantly extend time to first opioid with the blockade by 66.6%, increasing it from a mean of 5.6 hours to a mean of 10 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4 postoperative-pain
Started Sep 2018
Typical duration for phase_4 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2018
CompletedStudy Start
First participant enrolled
September 4, 2018
CompletedFirst Posted
Study publicly available on registry
September 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 8, 2020
CompletedMarch 3, 2021
March 1, 2021
1.6 years
September 4, 2018
March 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Time to first opioid
The time from catheters placement to the administration of opioids
24 hours postoperatively
Secondary Outcomes (6)
Pain intensity (NRS 0-10/10)
24 hours postoperatively
Total morphine consumption.
24 hours
Catheter displacement.
24 hours
Patient satisfaction with application of the catheters.
24 hours
The degree of morphine-related side effects (PONV, itching, fatigue, etc.).
24 hours
- +1 more secondary outcomes
Study Arms (2)
Intervention
ACTIVE COMPARATORRopivacaine
Control
PLACEBO COMPARATORIsotonic saline
Interventions
2 x 30 ml ropivacaine 0,2% and an elastomere pump with 200 ml ropivacaine 0,2%, infusion rate 8 ml/hour
2 x 30 mL isotonic saline and an elastomere pump with 200 ml isotonic saline, infusion rate 8 ml/hour
Eligibility Criteria
You may qualify if:
- + years of age.
- Scheduled for elective Caesarean Section in spinal anaesthesia.
- Have received thorough information, verbally and in written, and signed the "Informed Consent" form on participation in the trial.
You may not qualify if:
- Inability to cooperate
- Inability to understand Danish
- Allergy to local anaesthetics or opioids
- Excessive daily intake of opioids, according to the discretion of the investigator
- Local infection at the site of injection or systemic infection
- Difficult visualisation of muscular and fascial structures on ultrasound, necessary to correct blockade and catheter placement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of anaesthesiology
Roskilde, 4000, Denmark
Related Publications (1)
Steingrimsdottir GE, Hansen CK, Borglum J. Ultrasound-guided transmuscular quadratus lumborum catheters for elective caesarean section: A protocol for a single-centre, double-blind randomised trial. Acta Anaesthesiol Scand. 2020 Sep;64(8):1218-1223. doi: 10.1111/aas.13601. Epub 2020 Apr 22.
PMID: 32270474DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jens Børglum, MD PhD
Zealand University Hospital, University of Copenhagen
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2018
First Posted
September 10, 2018
Study Start
September 4, 2018
Primary Completion
April 8, 2020
Study Completion
April 8, 2020
Last Updated
March 3, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share